Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Reform: Senate May Amend Two Provisions In House Bill

Executive Summary

The Senate will vote on whether to limit debate on the House-passed patent reform bill when it reconvenes on Sept. 6. Senate Majority Leader Harry Reid, D-Nev., made a motion for the cloture vote before the August recess in hopes of getting a final bill through Congress quickly.
Advertisement

Related Content

It's All Over But The Signing: Patent Reform Bill Passes Senate Without Amendments
It's All Over But The Signing: Patent Reform Bill Passes Senate Without Amendments
GPhA's New CEO Ralph Neas Brings Health Reform Advocacy Experience
GPhA's New CEO Ralph Neas Brings Health Reform Advocacy Experience
PTO Seeks Early Public Input On Patent Reform Implementation
Patent Reform Clears House, But Provisions On PTO Fees, Patent Term Extension Differ From Senate
Patent Reform Clears House, But Provisions On PTO Fees, Patent Term Extension Differ From Senate
House Patent Reform Bill Hits Roadblock As Appropriations Cmte. Objects To PTO Fee Provision

Topics

Advertisement
UsernamePublicRestriction

Register

PS053741

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel